View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 18, 2011

US Researchers Say Antiretroviral Drugs Minimise HIV Risk

Researchers from University of Washington's International Clinical Research Center have announced successful results from a pre-exposure prophylaxis study, which showed that antiretroviral medications can reduce the risk of HIV infections. The study, conducted at nine research sites in

By cms admin

Researchers from University of Washington’s International Clinical Research Center have announced successful results from a pre-exposure prophylaxis study, which showed that antiretroviral medications can reduce the risk of HIV infections.

The study, conducted at nine research sites in Kenya and Uganda, involved 4,758 HIV serodiscordant couples in which one partner had HIV and the other did not.

Individuals who took a once-daily tenofovir tablet reported fewer HIV infections than those who received tenofovir in combination with emtricitabine and a placebo, reports The Times Of India.

University of Washington global health and medicine professor Connie Celum said the study demonstrates that antiretrovirals are a highly potent and fundamental cornerstone for HIV prevention.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology